Khaled Assi

Dr. Khaled Assi

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
YAYuosef. Al Ayoub
Yuosef. Al Ayoub
RGR.C. Gopalan
R.C. Gopalan
MNM. Najafzadeh
M. Najafzadeh
MMM.A. Mohammad
M.A. Mohammad
DAD. Anderson
D. Anderson
KAKhaled Assi
Khaled Assi
Extensive research has demonstrated the potential effectiveness of curcumin against various diseases, including asthma and cancers. However, few studies have used liquid-based vehicles in the preparation of curcumin formulations. Therefore, the current study proposed the use of nanoemulsion and microsuspension formulations to prepare nebulised curcuminoid for lung delivery. Furthermore, this work expressed a new approach to understanding the aerosol performance of nanoparticles compared to microsuspension formulations. The genotoxicity of the formulations was also assessed. Curcuminoid nanoemulsion formulations were prepared in three concentrations (100, 250 and 500 µg/ml) using limonene and oleic acid as oil phases, while microsuspension solutions were prepared by suspending curcuminoid particles in isotonic solution (saline solution) of 0.02% Tween 80. The average fine particle fraction (FPF) and mass median aerodynamic diameter (MMAD) of the nebulised microsuspension formulations ranged from 26% and 7.1 µm to 40% and 5.7 µm, for 1000 µg/ml and 100 µg/ml respectively. In a comparison of the low and high drug concentrations of the nebulised nanoemulsion, the average FPF and MMAD of the nebulised nanoemulsion formulations prepared with limonene oil ranged from 50% and 4.6 µm to 45% and 5.6 µm, respectively; whereas the FPF and MMAD of the nebulised nanoemulsion prepared with oleic acid oil ranged from 46% and 4.9 µm to 44% and 5.6 µm, respectively. The aerosol performance of the microsuspension formulations were concentration dependent, while the nanoemulsion formulations did not appear to be dependent on the curcuminoids concentration. The performance and genotoxicity results of the formulations suggest the suitability of these preparations for further inhalation studies in animals.

1 April 2006 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
KAKhaled Assi
Khaled Assi
WTW. Tarsin
W. Tarsin
HCH. Chrystyn
H. Chrystyn

6 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Fatma HaddadFatma Haddad
Fatma Haddad
NMNura Mohammed
Nura Mohammed
RGRajendran C. Gopalan
Rajendran C. Gopalan
YAYousef Al Ayoub
Yousef Al Ayoub
Md Talat NasimMd Talat Nasim
Md Talat Nasim
KAKhaled Assi
Khaled Assi
Epigallocatechin gallate (EGCG), the main ingredient in green tea, holds promise as a potential treatment for pulmonary arterial hypertension (PAH). However, EGCG has many drawbacks, including stability issues, low bioavailability, and a short half-life. Therefore, the purpose of this research was to develop and optimize an inhalable EGCG nano-liposome formulation aiming to overcome EGCG’s drawbacks by applying a design of experiments strategy. The aerodynamic behaviour of the optimum formulation was determined using the next-generation impactor (NGI), and its effects on the TGF-β pathway were determined using a cell-based reporter assay. The newly formulated inhalable EGCG liposome had an average liposome size of 105 nm, a polydispersity index (PDI) of 0.18, a zeta potential of −25.5 mV, an encapsulation efficiency of 90.5%, and a PDI after one month of 0.19. These results are in complete agreement with the predicted values of the model. Its aerodynamic properties were as follows: the mass median aerodynamic diameter (MMAD) was 4.41 µm, the fine particle fraction (FPF) was 53.46%, and the percentage of particles equal to or less than 3 µm was 34.3%. This demonstrates that the novel EGCG liposome has all the properties required to be inhalable, and it is expected to be deposited deeply in the lung. The TGFβ pathway is activated in PAH lungs, and the optimum EGCG nano-liposome inhibits TGFβ signalling in cell-based studies and thus holds promise as a potential treatment for PAH.

9 August 2019 in Crystals
Verified
Journal Article
Open access
PDF file
EKEram Khan
Eram Khan
ASAnuradha Shukla
Anuradha Shukla
KSKarnica Srivastava
Karnica Srivastava
DGDebraj Gangopadhyay
Debraj Gangopadhyay
KAKhaled Assi
Khaled Assi
Venu Gopal Rao  VangalaVenu Gopal Rao Vangala
Venu Gopal Rao Vangala
Pharmaceutical salt, nitrofurantoin–4-dimethylaminopyridine (NF-DMAP), along with its native components NF and DMAP are scrutinized by FT-IR and FT-Raman spectroscopy along with density functional theory so that an insight into the H-bond patterns in the respective crystalline lattices can be gained. Two different functionals, B3LYP and wB97X-D, have been used to compare the theoretical results. The FT-IR spectra obtained for NF-DMAP and NF clearly validate the presence of C33–H34⋅⋅⋅O4 and N23–H24⋅⋅⋅N9 hydrogen bonds by shifting in the stretching vibration of –NH and –CH group of DMAP+ towards the lower wavenumber side. To explore the significance of hydrogen bonding, quantum theory of atoms in molecules (QTAIM) has been employed, and the findings suggest that the N23–H24⋅⋅⋅N9 bond is a strong intermolecular hydrogen bond. The decrement in the HOMO-LUMO gap, which is calculated from NF → NF-DMAP, reveals that the active pharmaceutical ingredient is chemically less reactive compared to the salt. The electrophilicity index (ω) profiles for NF and DMAP confirms that NF is acting as electron acceptor while DMAP acts as electron donor. The reactive sites of the salt are plotted by molecular electrostatic potential (MEP) surface and calculated using local reactivity descriptors.

1 February 2022 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YAYuosef. Al Ayoub
Yuosef. Al Ayoub
ABAsma Buzgeia
Asma Buzgeia
GAGhadeer Almousawi
Ghadeer Almousawi
HMHassan Raza Ali Mazhar
Hassan Raza Ali Mazhar
BAB Alzouebi
B Alzouebi
KAKhaled Assi
Khaled Assi

24 December 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
RORahaf Oum
Rahaf Oum
YAYousef Al Ayoub
Yousef Al Ayoub
FHFatma Haddad
Fatma Haddad
BABayan Aburas
Bayan Aburas
APAnant Paradkar
Anant Paradkar
KAKhaled Assi
Khaled Assi